Neutrophilic Asthma Study With Navarixin (MK-7123, SCH 527123) (MK-7123-017)(COMPLETED)

NCT00632502 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

37

Enrollment

INDUSTRY

Sponsor class

Conditions

Neutrophilic Asthma

Interventions

DRUG: Navarixin
DRUG: Placebo
DRUG: Rescue medication

Sponsor

Merck Sharp & Dohme LLC